Haft Nicholas 4

Accession 0001209191-21-023074

CIK 0001733257other

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 6:05 PM ET

Size

30.2 KB

Accession

0001209191-21-023074

Form 4

Period: 2021-03-23

Director

Transactions

Conversion
Series C Preferred Stock
2021-03-23−212,893→ 0 total(indirect: See footnote)
→ Common Stock (212,893 underlying)
Conversion
Series D Preferred Stock
2021-03-23−1,150,481→ 0 total(indirect: See footnote)
→ Common Stock (1,150,481 underlying)
Conversion
Common Stock
2021-03-23+212,893→ 212,893 total(indirect: See footnote)
Purchase
Common Stock
2021-03-23$17.00/sh+882,351$14,999,967→ 882,351 total(indirect: See footnote)
Conversion
Series B Preferred Stock
2021-03-23−1,064,466→ 0 total(indirect: See footnote)
→ Common Stock (1,064,466 underlying)
Conversion
Series C Preferred Stock
2021-03-23−366,093→ 0 total(indirect: See footnote)
→ Common Stock (366,093 underlying)
Conversion
Common Stock
2021-03-23+172,942→ 172,942 total(indirect: See footnote)
Conversion
Common Stock
2021-03-23+366,093→ 1,430,559 total(indirect: See footnote)
Conversion
Series A Preferred Stock
2021-03-23−172,942→ 0 total(indirect: See footnote)
→ Common Stock (172,942 underlying)
Conversion
Series A Preferred Stock
2021-03-23−143,831→ 0 total(indirect: See footnote)
→ Common Stock (143,831 underlying)
Conversion
Common Stock
2021-03-23+143,831→ 143,831 total(indirect: See footnote)
Conversion
Common Stock
2021-03-23+1,064,466→ 1,064,466 total(indirect: See footnote)
Conversion
Common Stock
2021-03-23+1,150,481→ 1,150,481 total(indirect: See footnote)

Footnotes (7)

[F1]Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.
[F2]The securities are held by M3 Ventures - Finch LLC ("M3 Ventures I"). The Reporting Person is the manager of M3 Ventures I.
[F3]The securities are held by NBTT 2 Investments LLC ("NBTT"). The Reporting Person is the manager of NBTT.
[F4]The securities are held by M3 Ventures - Finch II LLC ("M3 Ventures II"). The Reporting Person is the manager of M3 Ventures II.
[F5]The securities are held by Arcos Ventures SPV LLC ("Arcos"). The Reporting Person is the manager of Arcos.
[F6]The securities are held by OMX Ventures SPV-Finch LLC ("OMX I"). The Reporting Person is the manager of OMX I.
[F7]The securities are held by OMX Ventures SPV-Finch II LLC ("OMX II"). The Reporting Person is the manager of OMX II.

Documents

1 file

Finch Therapeutics Group, Inc.

CIK 0001733257

Entity typeother